Yunyueng Jang
Overview
Explore the profile of Yunyueng Jang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cha R, Park M, Baek Y, Lee Y, Jang Y, Jang Y, et al.
Virus Res
. 2025 Feb;
353:199541.
PMID: 39894372
During the 2022-2023 winter season in South Korea, a novel clade 2.3.4.4b H5N1 HPAIV was first detected in wild birds, which then subsequently caused multiple outbreaks in poultry farms and...
2.
Jang Y, Baek Y, Lee Y, Cha R, Choi Y, Park M, et al.
Poult Sci
. 2024 Dec;
104(1):104570.
PMID: 39631283
Reverse genetics (RG) systems are extensively utilized to investigate the characteristics of influenza viruses and develop vaccines, predominantly relying on human RNA polymerase I (pol I). However, the efficiency of...
3.
Seo H, Jang Y
Arch Microbiol
. 2024 Sep;
206(10):393.
PMID: 39240318
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic disease affecting camels and humans. The live attenuated vaccine represents a candidate human vaccine because it can induce strong immune responses...
4.
Heo G, Kang Y, An S, Kim Y, Cha R, Jang Y, et al.
Emerg Infect Dis
. 2024 May;
30(6):1223-1227.
PMID: 38703023
Highly pathogenic avian influenza H5N6 and H5N1 viruses of clade 2.3.4.4b were simultaneously introduced into South Korea at the end of 2023. An outbreak at a broiler duck farm consisted...
5.
Seo H, Jang Y, Kwak D
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675818
Middle East respiratory syndrome coronavirus (MERS-CoV) causes fatal infections, with about 36% mortality in humans, and is endemic to the Middle East. MERS-CoV uses human dipeptidyl peptidase 4 (hDPP4) as...
6.
Seo H, Jang Y, Kwak D
Vaccines (Basel)
. 2023 Aug;
11(8).
PMID: 37631921
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe diseases in humans. Camels act as intermediate hosts for MERS-CoV. Currently, no licensed vaccine is available for this virus. We have developed...
7.
Kuruppuarachchi K, Jang Y, Seo S
Front Biosci (Landmark Ed)
. 2022 Dec;
27(11):316.
PMID: 36472114
Background: The recently emerged variants of the severe acute respiratory coronavirus 2 (SARS-CoV-2) pose a threat to public health. Understanding the pathogenicity of these variants is a salient factor in...
8.
Kuruppuarachchi K, Jang Y, Seo S
Front Biosci (Landmark Ed)
. 2022 Oct;
27(9):268.
PMID: 36224020
Background: Over the last 20 years, circulating highly pathogenic (HP) Asian H5 subtype avian influenza viruses have caused global pandemics in poultry and sporadic infections in humans. Vaccines are a...
9.
Jang Y, Seo S
Arch Virol
. 2021 Oct;
167(1):67-75.
PMID: 34693488
Highly pathogenic H5Nx avian influenza viruses constantly threaten the poultry industry and humans and have pandemic potential. These viruses continuously evolve, requiring a universal vaccine to protect chickens from members...
10.
Seo S, Jang Y
Vaccines (Basel)
. 2020 Oct;
8(4).
PMID: 33022950
A safe and effective vaccine that can provide herd immunity against severe acute respiratory syndrome coronavirus (SARS-CoV-2) is urgently needed to stop the spread of this virus among humans. Many...